NCT02056522View on ClinicalTrials.gov

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

CompletedOBSERVATIONAL
Enrollment

357

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

July 31, 2018

Conditions
Skin Lesions
Trial Locations (2)

13100

Ziv Medical Center, Safed

Unknown

Clalit Health Services, Kiryat Bialik

Sponsors

Lead Sponsor

Orlucent, Inc
All Listed Sponsors
lead

Orlucent, Inc

INDUSTRY

NCT02056522 - Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging | Biotech Hunter | Biotech Hunter